Get Level 2

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. GSK publishes provisional 2023 dividend dates

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,979.50    -3.50 (-0.18%)
Bid:
1,982.50
Ask:
1,983.50
Spread: 1.00 (0.05%)
Market Cap: £79.31b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

GSK publishes provisional 2023 dividend dates

24 Nov 2022 15:00

RNS Number : 5143H
GSK PLC
24 November 2022
 

GSK plc

 

GSK publishes provisional dividend dates

 

GSK announces the following dividend dates for 2023:

 

Results

Announcement date

Ex-dividend date

Record date

Last date for DRIP elections

Payable

Q1 2023

Wednesday 26 April 2023

Thursday 18 May 2023

Friday 19 May 2023

Wednesday 21 June 2023

Thursday 13 July 2023

Q2 2023

Wednesday 26 July 2023

Thursday 17 August 2023

Friday 18 August 2023

Wednesday 20 September 2023

Thursday 12 October 2023

Q3 2023

Wednesday 1 November 2023

Thursday 16 November 2023

Friday 17 November 2023

Monday 18 December 2023

Thursday 11 January 2024

Q4 2023

(Final)

Wednesday 31 January 2024

Thursday 22 February 2024

Friday 23 February 2024

Tuesday 19 March 2024

Thursday 11 April 2024

 

These dates are indicative and may be subject to change.

 

 

 

V A Whyte

Company Secretary

 

24 November 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBKQBKDBDDDDB
12345678910
Date   Source Headline
29th Jun 20263:00 pmRNSTransaction in Own Shares
29th Jun 20263:00 pmRNSHolding(s) in Company
26th Jun 20263:00 pmRNSHolding(s) in Company
24th Jun 20263:30 pmRNSDirector/PDMR Shareholding
24th Jun 20262:52 pmRNSGSK announces tender offer to acquire Nuvalent
23rd Jun 20263:30 pmRNSDirector/PDMR Shareholding
22nd Jun 20263:00 pmRNSTransaction in Own Shares
17th Jun 20264:06 pmRNScUTI oral antibiotic Tebipenem approved by US FDA
15th Jun 20263:00 pmRNSTransaction in Own Shares
12th Jun 20267:00 amRNSMomelotinib orphan drug designations for VEXAS
11th Jun 20263:30 pmRNSDirector/PDMR Shareholding
10th Jun 20263:30 pmRNSDirector/PDMR Shareholding
9th Jun 20265:51 pmRNSDr Hal Barron – New Directorship
9th Jun 20267:00 amRNSGSK enters agreement to acquire Nuvalent, Inc.
8th Jun 20263:00 pmRNSTransaction in Own Shares
1st Jun 20263:00 pmRNSTotal Voting Rights
1st Jun 20263:00 pmRNSTransaction in Own Shares
28th May 20269:30 amRNSPositive Phase 3 data for bepirovirsen
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20263:00 pmRNSAdmission to Trading
26th May 20263:00 pmRNSTransaction in Own Shares
22nd May 202610:30 amRNSQ2 2026 Results Date Confirmed - 28 July 2026
20th May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:30 pmRNSDirector/PDMR Shareholding
18th May 20263:00 pmRNSTransaction in Own Shares
18th May 20267:00 amRNSJapan MHLW approves Arexvy for adults 18-49 AIR
14th May 20263:30 pmRNSDirector/PDMR Shareholding
11th May 20263:30 pmRNSDirector/PDMR Shareholding
11th May 20267:05 amRNSCollaboration with CTTQ for bepirovirsen
11th May 20267:00 amRNSGSK - final tranche of share buyback programme
6th May 20266:22 pmRNSResult of AGM
5th May 20263:30 pmRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSHolding(s) in Company
1st May 20263:00 pmRNSTotal Voting Rights
29th Apr 20263:30 pmRNSDirector/PDMR Shareholding
29th Apr 20267:00 amRNS1st Quarter Results
28th Apr 20263:30 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSBepirovirsen priority review US filing acceptance
27th Apr 202612:00 pmRNSEfimosfermin granted US/EU regulatory designations
27th Apr 20267:00 amRNSTESARO update on AnaptysBio Inc. litigation
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20263:30 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSBlenrep approved in China for 2L+ multiple myeloma
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:30 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
ADAM
ADAM.L
LSE
0.00%
HHV
Hargreave
LSE
0.00%
IPEL
IPEL.L
LSE
0.00%
ASHM
Ashmore Group
LSE
0.56%
RAT
Rathbone
LSE
-1.37%
Trending
GGP
Greatland Resources
LSE
-1.71%
IMM
Immupharma
LSE
3.09%
DFDV
Defi Dev Corp
LSE
158.26%
NTVO
Nativo Resources
LSE
-15.38%
KEFI
Kefi Gold & Copper
LSE
0.19%